Cordyceps Sunshine Biotech Holdings Co., Ltd. Cost of Revenue
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Cost of Revenue of $484.61 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-05-15
- Cordyceps Sunshine Biotech Holdings Co., Ltd. cost of revenue for the quarter ending 2023-12-31 was $30.84K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 8 month | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $484.61K 20-F · filed 2026-05-15 | ||||
| 2024-12-31 | $347.00K 20-F · filed 2026-05-15 | $719.72K 20-F · filed 2025-06-13 | |||
| 2023-12-31 | $30.84K derived: 20-F 12 month − 6-K 9 month · filed 2026-05-15 | $116.15K 20-F · filed 2026-05-15 | |||
| 2023-09-30 | $85.30K 6-K · filed 2023-11-13 | ||||
| 2022-12-31 | $13.75K 20-F/A · filed 2025-09-23 | $515.46K 20-F · filed 2023-05-15 | |||
| 2021-12-31 | $1.06M 20-F · filed 2023-05-15 | ||||
| 2020-12-31 | $40.65K 20-F · filed 2023-05-15 |